Literature DB >> 25898043

Newborn screening: evolving challenges in an era of rapid discovery.

Donald B Bailey1, Lisa Gehtland1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25898043      PMCID： PMC7990125          DOI： 10.1001/jama.2014.17488

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  From public health emergency to public health service: the implications of evolving criteria for newborn screening panels.

Authors:  Scott D Grosse; Coleen A Boyle; Aileen Kenneson; Muin J Khoury; Benjamin S Wilfond
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

2.  Newborn screening for Krabbe disease: the New York State model.

Authors:  Patricia K Duffner; Michele Caggana; Joseph J Orsini; David A Wenger; Marc C Patterson; Carl J Crosley; Joanne Kurtzberg; Georgianne L Arnold; Maria L Escolar; Darius J Adams; Mary R Andriola; Alan M Aron; Emma Ciafaloni; Alexandra Djukic; Richard W Erbe; Patricia Galvin-Parton; Laura E Helton; Edwin H Kolodny; Barry E Kosofsky; David F Kronn; Jennifer M Kwon; Paul A Levy; Jill Miller-Horn; Thomas P Naidich; Joan E Pellegrino; James M Provenzale; Stanley J Rothman; Melissa P Wasserstein
Journal:  Pediatr Neurol       Date:  2009-04       Impact factor: 3.372

3.  The ethical hazards and programmatic challenges of genomic newborn screening.

Authors:  Aaron J Goldenberg; Richard R Sharp
Journal:  JAMA       Date:  2012-02-01       Impact factor: 56.272

4.  Mandatory versus voluntary consent for newborn screening?

Authors:  Lainie Friedman Ross
Journal:  Kennedy Inst Ethics J       Date:  2010-12

5.  Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children.

Authors:  Alex R Kemper; Nancy S Green; Ned Calonge; Wendy K K Lam; Anne M Comeau; Aaron J Goldenberg; Jelili Ojodu; Lisa A Prosser; Susan Tanksley; Joseph A Bocchini
Journal:  Genet Med       Date:  2013-08-01       Impact factor: 8.822

6.  Newborn screening: toward a uniform screening panel and system.

Authors: 
Journal:  Genet Med       Date:  2006-05       Impact factor: 8.822
  6 in total
  13 in total

Review 1.  Advanced technologies for the molecular diagnosis of fragile X syndrome.

Authors:  Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2015-10-21       Impact factor: 5.225

2.  Whole-Genome Screening of Newborns? The Constitutional Boundaries of State Newborn Screening Programs.

Authors:  Jaime S King; Monica E Smith
Journal:  Pediatrics       Date:  2016-01       Impact factor: 7.124

Review 3.  A Review on Spinal Muscular Atrophy: Awareness, Knowledge, and Attitudes.

Authors:  Rebecca R Moultrie; Julia Kish-Doto; Holly Peay; Megan A Lewis
Journal:  J Genet Couns       Date:  2016-04-16       Impact factor: 2.537

Review 4.  Ethical issues in pediatric genetic testing and screening.

Authors:  Jeffrey R Botkin
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

5.  Newborn Screening Collection and Delivery Processes in Michigan Birthing Hospitals: Strategies to Improve Timeliness.

Authors:  Amy L Cochran; Beth A Tarini; Mary Kleyn; Gabriel Zayas-Cabán
Journal:  Matern Child Health J       Date:  2018-10

6.  Parental intentions to enroll children in a voluntary expanded newborn screening program.

Authors:  Ryan S Paquin; Holly L Peay; Lisa M Gehtland; Megan A Lewis; Donald B Bailey
Journal:  Soc Sci Med       Date:  2016-07-29       Impact factor: 4.634

7.  Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project.

Authors:  Ozge Ceyhan-Birsoy; Jaclyn B Murry; Kalotina Machini; Matthew S Lebo; Timothy W Yu; Shawn Fayer; Casie A Genetti; Talia S Schwartz; Pankaj B Agrawal; Richard B Parad; Ingrid A Holm; Amy L McGuire; Robert C Green; Heidi L Rehm; Alan H Beggs
Journal:  Am J Hum Genet       Date:  2019-01-03       Impact factor: 11.025

8.  Evaluating parents' decisions about next-generation sequencing for their child in the NC NEXUS (North Carolina Newborn Exome Sequencing for Universal Screening) study: a randomized controlled trial protocol.

Authors:  Laura V Milko; Christine Rini; Megan A Lewis; Rita M Butterfield; Feng-Chang Lin; Ryan S Paquin; Bradford C Powell; Myra I Roche; Katherine J Souris; Donald B Bailey; Jonathan S Berg; Cynthia M Powell
Journal:  Trials       Date:  2018-06-28       Impact factor: 2.279

9.  A next-generation newborn screening pilot study: NGS on dried blood spots detects causal mutations in patients with inherited metabolic diseases.

Authors:  F Boemer; C Fasquelle; S d'Otreppe; C Josse; V Dideberg; K Segers; V Guissard; V Capraro; F G Debray; V Bours
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379

10.  Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates.

Authors:  Dale L Bodian; Elisabeth Klein; Ramaswamy K Iyer; Wendy S W Wong; Prachi Kothiyal; Daniel Stauffer; Kathi C Huddleston; Amber D Gaither; Irina Remsburg; Alina Khromykh; Robin L Baker; George L Maxwell; Joseph G Vockley; John E Niederhuber; Benjamin D Solomon
Journal:  Genet Med       Date:  2015-09-03       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.